T2 Biosystems Overview
T2 Biosystems (TTOO) has a ROE of 369.21%, above the Industrials sector average of 20.47%.
Get informed when a big investor buys or sells
+ Follow369.21%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for TTOO is 369.21%. That is above the Industrials sector average of 20.47%. Investors often review this figure alongside T2 Biosystems's historical trend and sector peers before judging valuation or financial health.
Against Industrials companies, TTOO currently prints 369.21% for ROE, while the sector average sits near 20.47%. That is roughly 1703.3% above the sector mean. Large gaps often invite a closer look at T2 Biosystems's growth, margins, and balance sheet.
Return on Equity shows how effectively T2 Biosystems converts resources into returns. At 369.21%, TTOO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TTOO's ROE (369.21%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack T2 Biosystems's ROE against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.
